Patients with LMNA variants showed no improvement in the left heart function, with right ventricular enlargement and worsening tricuspid regurgitation, suggesting progression to right-sided heart failure.
Abstract
Objective The relationship between genotypes and longitudinal changes in the comprehensive cardiac function and biomarkers in patients with idiopathic cardiomyopathy has not yet been fully elucidated.Methods Patients with suspected idiopathic cardiomyopathy who underwent genetic testing for cardiomyopathy-related genes were included. Comprehensive echocardiographic parameters and biomarkers at the initial examinations and final follow-ups were analyzed based on the genotypes.Results Genetic testing was conducted on 123 patients, identifying variants in the lamin A/C (LNMA) in 16 patients (13%), titin (TTN) in seven patients (6%), and other cardiomyopathy-related genes in 16 patients (13%). No genetic variants were detected in 84 patients (68%). Follow-up echocardiography was performed in 110 (89%) of 123 patients. While patients with TTN truncating variants had a significantly lower baseline left ventricular ejection fraction (LVEF), a significant improvement was observed during the follow-up (31 to 55%, p=0.008). There were no significant differences in the baseline parameters of right ventricular function among the genotypes. However, patients with LMNA variants showed a significantly larger right ventricular end-diastolic area (p=0.035), inferior vena cava diameter (p=0.047), and a higher prevalence of moderate or severe tricuspid regurgitation (p<0.001) at follow-up than those without. Cardiovascular composite events tended to occur most frequently in patients with LMNA variants (n=6, 38%), whereas no events were observed in patients with TNN variants (p=0.161). Patients with TTN truncating variants had a low baseline LVEF and a favorable response to treatment.Conclusion Patients with LMNA variants showed no improvement in the left heart function, with right ventricular enlargement and worsening tricuspid regurgitation, suggesting progression to right-sided heart failure.
Genetic background was associated with distinct myocardial fibrosis phenotypes and provided prognostic information beyond conventional CMR-derived fibrosis and functional phenotypes in DCM.
Y. Li, Yuan-Wei Xu, Yang Guo et al.· JACC Cardiovascular Imaging· 0 citations
In this population of children with primary HCM, severe LVH was associated with a younger age at enrollment and a higher likelihood of harboring a pathogenic variant in MYBPC3.
E. Pahl, Stephanie M. Ware, Ling Shi et al.· JACC. Heart failure· 1 citation
Most patients with MYH7-related HCM presented with a benign phenotype over the long term, and the risks of AF, SCD, and worsening HF throughout life justify regular monitoring, and the need to look for particular genetic profiles that may potentially help tailored management strategies.
Catarina Gregório, M. Vilela, Ana Beatriz Garcia et al.· Revista Portuguesa de Cardio...· 0 citations
The findings support the use of the Ross functional classification as a simple bedside tool, useful in early prognostic stratification in children with dilated cardiomyopathy, although its discriminatory performance was modest.
Adelina Sorescu, Cristina Isabel Viorica Ghiță, S. Stoleru et al.· Pediatric Reports· 0 citations
Combined electrical and mechanical atrial dysfunction characterized a subgroup with markedly elevated risk, underscoring the clinical relevance of integrating both domains when diagnosing AtCM.
Hiroki Uehara, M. Kambayashi, Toshiyuki Nagai et al.· JACC: Advances· 0 citations
BACKGROUND
Indices reflecting the discordance between QRS complex voltages on ECG and left ventricular (LV) wall thickness or LV mass index on echocardiogram (echo) have enabled identification of cardiac amyloidosis (CA) among patients with hypertrophic hearts. However, this evidence comes from studies that have exclud...
Valentina Allegro, L. Pagura, A. Porcari et al.· Journal of the American Hear...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.